Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: a systematic review
KI Notarte, I Guerrero‐Arguero… - Journal of medical …, 2022 - Wiley Online Library
Accumulating evidence shows a progressive decline in the efficacy of coronavirus disease
2019 (COVID‐19)(severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) …
2019 (COVID‐19)(severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) …
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety
H Meng, J Mao, Q Ye - Journal of medical virology, 2022 - Wiley Online Library
At present, the global COVID‐19 epidemic has not been completely controlled, and
epidemic prevention and control still face severe challenges. As there is no specific …
epidemic prevention and control still face severe challenges. As there is no specific …
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
M Belik, P Jalkanen, R Lundberg, A Reinholm… - Nature …, 2022 - nature.com
Abstract Two COVID-19 mRNA (of BNT162b2, mRNA-1273) and two adenovirus vector
vaccines (ChAdOx1 and Janssen) are licensed in Europe, but optimization of regime and …
vaccines (ChAdOx1 and Janssen) are licensed in Europe, but optimization of regime and …
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
Objectives mRNA vaccines, including Comirnaty (BNT162b2 mRNA, BioNTech-Pfizer), elicit
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers
Objectives The waning of humoral immunity after COVID-19 vaccine booster (third dose) has
not yet been fully evaluated. This study updates data on anti-SARS-CoV-2 spike protein …
not yet been fully evaluated. This study updates data on anti-SARS-CoV-2 spike protein …
Efficacy of COVID-19 vaccine booster doses in older people
C Mattiuzzi, G Lippi - European Geriatric Medicine, 2022 - Springer
Purpose We provide here an updated analysis on efficacy of COVID-19 vaccine booster
doses in older people (ie, aged≥ 80 years) based on ongoing Italian nationwide COVID-19 …
doses in older people (ie, aged≥ 80 years) based on ongoing Italian nationwide COVID-19 …
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare …
I Sarrigeorgiou, D Moschandreou, A Dimitriadis… - PLoS …, 2022 - journals.plos.org
Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
Differential dynamics of SARS-CoV-2 binding and functional antibodies upon BNT162b2 vaccine: A 6-month follow-up
G Matusali, G Sberna, S Meschi, G Gramigna… - Viruses, 2022 - mdpi.com
To investigate the dynamic association among binding and functional antibodies in health-
care-workers receiving two doses of BNT162b2 mRNA COVID-19-vaccine, SARS-CoV-2 …
care-workers receiving two doses of BNT162b2 mRNA COVID-19-vaccine, SARS-CoV-2 …
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
M Belik, O Liedes, S Vara, A Haveri, S Pöysti… - Frontiers in …, 2023 - frontiersin.org
Introduction The prime-boost COVID-19 mRNA vaccination strategy has proven to be
effective against severe COVID-19 disease and death. However, concerns have been raised …
effective against severe COVID-19 disease and death. However, concerns have been raised …
A four-channel surface plasmon resonance sensor functionalized online for simultaneous detections of anti-SARS-CoV-2 antibody, free viral particles, and neutralized …
T Dong, C Han, M Jiang, T Zhang, Q Kang, P Wang… - ACS …, 2022 - ACS Publications
Current tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detect
either the constituent nucleic acids/proteins of the viral particles or antibodies specific to the …
either the constituent nucleic acids/proteins of the viral particles or antibodies specific to the …